Ultimately, a better understanding of the DNA methylation events associated with oncogenic KRAS expression could enhance therapeutic approaches for KRAS-driven cancers and provide a platform for understanding the intrinsic heterogeneous nature of these cancers. This evidence concerns the gene KRAS and cancer.